Mark Williams

Dr. Mark E. Williams is a Harvard-trained, double board-certified (Internal Medicine, Nephrology) full-time practicing academic nephrologist. He is Director of Dialysis at Beth Israel Deaconess Medical Center, a Senior Staff Physician at the Joslin Diabetes Center, and an Associate Professor of Medicine at Harvard Medical School. Dr. Williams is a nationally and Internationally-recognized leader in the field of end-stage renal disease, diabetes complications, and all forms of renal replacement therapy, including acute and chronic dialysis and therapeutic plasma exchange. He is a Fellow of the American Society of Nephrology, where he has served on numerous committees and given multiple invited lectures, and a Fellow of the American College of Physicians. He has been recognized for his leadership as board chairman of the National Kidney Foundation affiliate for New England, as chairman of the NKF national Scientific Council for Diabetic Kidney Disease, and chairman of the national NKF Public Policy Committee. He has served on Editorial Boards of several leading kidney journals, including the Clinical Journal of the American Society of Nephrology. Dr. Williams’ research has been presented at numerous National and International nephrology meetings. He currently serves on the board of directors of the ESRD Network of New England. He has been cited as one of America’s Top Physicians by the National Consumer Advisory Board, and listed among Boston Magazine’s Top Doctors on multiple occasions. A major current focus of Dr. Williams’ academic activity is on the technical aspects of renal replacement therapy and on the barriers to quality care in acute and chronic dialysis.

Clinical Interests

• End-Stage Renal Disease
• Dialysis/Transplantation

Education

Medical School: Indiana University School of Medicine

Residency: Boston University Medical Center

Fellowship: Beth Israel Deaconess Medical Center